The global remote patient monitoring market was estimated at $703 million in 2015 and is expected to hit $2,130 million by 2022, growing at a CAGR of 17.0% during the forecast period. The report offers an in-depth analysis of drivers & opportunities, evolving market trends, competitive scenario, key segments, and market size & estimations. These insights are helpful for market players, investors, stakeholders, and new entrants to understand the market and gain a major market share as well as international presence.
Rising incidence of chronic diseases, and high-end technological advancements, have fueled the growth of the global remote patient monitoring market. On the other hand, unstable reimbursement regulations, and limited awareness about the technology have happened to curb the growth to some extent. However, growing developments in emerging markets have created a number of lucrative opportunities in the segment.
Get Sample Copy of this Report at: https://www.alliedmarketresearch.com/request-sample/1727
The report segments the market into condition, component and geography. Based on component, the market is divided into Congestive Heart Failure (CHF), Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Blood Pressure, Mental Health and Others. Based on component, the market is bifurcated into devices and software. By geography, the market is analyzed across various regions including North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA).
By condition the CHF segment accounted for the largest revenue in 2015 and is expected to dominate during the study period. On the other hand, the diabetes segment is anticipated to grow at the fastest CAGR throughout 2015-2022. By component, the devices segment will be both the highest revenue generating and fastest growing segment of the global remote patient monitoring (RPM) market. Based on geography, U.S. contributed to the largest share in 2015 and is projected to be dominant till 2022. Simultaneously, Saudi Arabia market is anticipated to grow at the fastest CAGR of 21.3% throughout the period.
Send Enquiry on this Report at: https://www.alliedmarketresearch.com/purchase-enquiry/1727
The key players profiled in the report include Boston Scientific Corporation, General Electric Company, Nihon Kohden Corporation, Johnson and Johnson and Omron Corporation Aerotel Medical Systems (1988) Ltd., Medtornic Plc, Masimo Corporation, Abbott Laboratories, and Biotronik SE & Co. KG. They have adopted a number of high-end strategies to retain a strong stand in the industry. The other players discussed in the value chain take in Jawbone, Microlife Corporation, SHL Telemedicine, Schiller AG, A&D Company Limited, Aipermon GmbH & Co. KG, Sorin Group, and Docobo Ltd.
About us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides a one-stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies the client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to aid the clients to turn into a prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
